MSB 1.95% $1.05 mesoblast limited

CHF - The real phase 3 headlines, page-38

  1. 2,599 Posts.
    lightbulb Created with Sketch. 1634
    Hi Shakespeare,
    55,959 patients in a heart failure survival diagnosis trial run in the UK between 2000-2017.
    30,906 dead.
    I was interested reading their finding re patient admissions below- perhaps that's why we chose our endpoint?
    They had a longer term 50% mortality rate. Now I'm no scientist but a 60% improvement on 50% for class II is 80% survival. Same as our Ards numbers!

    People with established heart failure who need to be admitted to hospital for acute decompensation have high mortality rates; up to one in six patients die during admission or within 30 days after discharge.8910 Survival for screen detected heart failure is more favourable, with around half of all study participants alive at five years.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.05
Change
0.020(1.95%)
Mkt cap ! $1.193B
Open High Low Value Volume
$1.02 $1.07 $1.02 $7.487M 7.196M

Buyers (Bids)

No. Vol. Price($)
3 29708 $1.05
 

Sellers (Offers)

Price($) Vol. No.
$1.05 50000 1
View Market Depth
Last trade - 16.10pm 10/06/2024 (20 minute delay) ?
Last
$1.05
  Change
0.020 ( 1.89 %)
Open High Low Volume
$1.02 $1.07 $1.02 1379563
Last updated 15.59pm 10/06/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.